Exozymes earnings were -$10.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest EXOZ earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.9M, up 21.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EXOZ reported annual earnings of -$9.2M, with 56.3% growth. The next EXOZ earnings date is Nov 12, 2026.
On EXOZ's earnings call on Aug 20, 2026, Exozymes (NASDAQ: EXOZ) reported Q2 2026 earnings per share (EPS) of -$0.33, up 17.86% year over year. Total EXOZ earnings for the quarter were -$2.88 million. In the same quarter last year, Exozymes's earnings per share (EPS) was -$0.28.
The next EXOZ earnings call is Nov 12, 2026. Add EXOZ to your watchlist to be reminded of Exozymes's next earnings date.
What was EXOZ's earnings growth in the past year?
As of Exozymes's earnings date in Aug 20, 2026, Exozymes's earnings has grown year over year. EXOZ earnings in the past year totalled -$10.19 million.
Is Exozymes profitable or losing money?
As of the last Exozymes earnings report, Exozymes is currently losing money. Exozymes's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$10.19 million, a 32.19% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.